Joint Filing AgreementJoint Filing Agreement • February 12th, 2019 • Tekla Capital Management LLC • In vitro & in vivo diagnostic substances
The undersigned persons, on February 12, 2019, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of ARCA biopharma, Inc. on December 31, 2018.
Joint Filing AgreementJoint Filing Agreement • February 14th, 2012 • Hambrecht & Quist Capital Management LLC • Pharmaceutical preparations
The undersigned persons, on February 14, 2012, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of A.P. Pharma, Inc. on December 31, 2011.
Joint Filing AgreementJoint Filing Agreement • February 13th, 2017 • Tekla Capital Management LLC • Services-commercial physical & biological research
The undersigned persons, on February 13, 2017, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Pieris Pharmaceuticals, Inc. on December 31, 2016.
Joint Filing AgreementJoint Filing Agreement • February 14th, 2012 • Hambrecht & Quist Capital Management LLC • In vitro & in vivo diagnostic substances
The undersigned persons, on February 14, 2011, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of MZT Holdings, Inc. on December 31, 2011.
Joint Filing AgreementJoint Filing Agreement • January 21st, 2022 • Tekla Capital Management LLC • Pharmaceutical preparations
The undersigned persons, on January 21, 2022, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Rallybio Corp. on December 31, 2021.
Joint Filing AgreementJoint Filing Agreement • February 13th, 2017 • Tekla Capital Management LLC • In vitro & in vivo diagnostic substances
The undersigned persons, on February 13, 2017, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of ARCA biopharma, Inc. on December 31, 2016.
Joint Filing AgreementJoint Filing Agreement • February 14th, 2014 • Tekla Capital Management LLC • Pharmaceutical preparations
The undersigned persons, on February 14, 2014, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Intellipharmaceutics International Inc. on December 31, 2013.
Joint Filing AgreementJoint Filing Agreement • February 12th, 2019 • Tekla Capital Management LLC • Pharmaceutical preparations
The undersigned persons, on February 12, 2019, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Verona Pharma plc on December 31, 2018.
Joint Filing AgreementJoint Filing Agreement • February 12th, 2016 • Tekla Capital Management LLC • Surgical & medical instruments & apparatus
The undersigned persons, on February 12, 2016, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Alliqua BioMedical, Inc. on December 31, 2015.
Joint Filing AgreementJoint Filing Agreement • January 23rd, 2023 • Tekla Capital Management LLC • Pharmaceutical preparations
The undersigned persons, on January 23, 2023, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Rallybio Corp. on December 31, 2022.
Joint Filing AgreementJoint Filing Agreement • February 14th, 2013 • Tekla Capital Management LLC • Pharmaceutical preparations
The undersigned persons, on February 14, 2013, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of A.P. Pharma, Inc. on December 31, 2012.
Joint Filing AgreementJoint Filing Agreement • January 24th, 2020 • Tekla Capital Management LLC • Pharmaceutical preparations
The undersigned persons, on January 24, 2020, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Zyla Life Sciences on December 31, 2019.
Joint Filing AgreementJoint Filing Agreement • February 12th, 2018 • Tekla Capital Management LLC • In vitro & in vivo diagnostic substances
The undersigned persons, on February 12, 2018, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of ARCA biopharma, Inc. on December 31, 2017.
Joint Filing AgreementJoint Filing Agreement • February 12th, 2016 • Tekla Capital Management LLC • Services-commercial physical & biological research
The undersigned persons, on February 12, 2016, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Pieris Pharmaceuticals, Inc. on December 31, 2015.
Joint Filing AgreementJoint Filing Agreement • February 12th, 2018 • Tekla Capital Management LLC • Surgical & medical instruments & apparatus
The undersigned persons, on February 12, 2018, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Alliqua BioMedical, Inc. on December 31, 2017.
Joint Filing AgreementJoint Filing Agreement • February 10th, 2011 • Hambrecht & Quist Capital Management LLC • Pharmaceutical preparations
The undersigned persons, on February 10, 2011, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Intellipharmaceutics International Inc. on January 31, 2011.
Joint Filing AgreementJoint Filing Agreement • January 29th, 2021 • Tekla Capital Management LLC • Pharmaceutical preparations
The undersigned persons, on January 29, 2021, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Zyla Life Sciences on December 31, 2020.
Joint Filing AgreementJoint Filing Agreement • February 12th, 2016 • Tekla Capital Management LLC • In vitro & in vivo diagnostic substances
The undersigned persons, on February 12, 2016, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of ARCA biopharma, Inc. on December 31, 2015.
Joint Filing AgreementJoint Filing Agreement • February 14th, 2014 • Tekla Capital Management LLC • Pharmaceutical preparations
The undersigned persons, on February 14, 2014, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Heron Therapeutics, Inc. on December 31, 2013.
Joint Filing AgreementJoint Filing Agreement • February 14th, 2012 • Hambrecht & Quist Capital Management LLC • Surgical & medical instruments & apparatus
The undersigned persons, on February 14, 2012, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Medwave, Inc. on December 31, 2011.
Joint Filing AgreementJoint Filing Agreement • February 13th, 2017 • Tekla Capital Management LLC • Pharmaceutical preparations
The undersigned persons, on February 13, 2017, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Verona Pharma plc on December 31, 2016.
Joint Filing AgreementJoint Filing Agreement • February 13th, 2017 • Tekla Capital Management LLC • Surgical & medical instruments & apparatus
The undersigned persons, on February 13, 2017, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Alliqua BioMedical, Inc. on December 31, 2016.
Joint Filing AgreementJoint Filing Agreement • February 13th, 2015 • Tekla Capital Management LLC • Pharmaceutical preparations
The undersigned persons, on February 13, 2015, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Intellipharmaceutics International Inc. on December 31, 2014.
Joint Filing AgreementJoint Filing Agreement • January 24th, 2020 • Tekla Capital Management LLC • In vitro & in vivo diagnostic substances
The undersigned persons, on January 24, 2020, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of ARCA biopharma, Inc. on December 31, 2019.
Joint Filing AgreementJoint Filing Agreement • February 12th, 2018 • Tekla Capital Management LLC • Services-commercial physical & biological research
The undersigned persons, on February 12, 2018, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the Common Stock of Pieris Pharmaceuticals, Inc. on December 31, 2017.
